Skip to main content
PMC home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2008 Mar 6;23(1):67–70. doi: 10.1007/s12291-008-0016-4

Relationship between free iron and glycated hemoglobin in uncontrolled type 2 diabetes patients associated with complications

Jeevan K Shetty 1,✉, Mungli Prakash 1, Mohammad S Ibrahim 1
PMCID: PMC3453647  PMID: 23105724

Abstract

Free iron in serum has been found in several disease conditions including diabetes. In the present work, we studied the relationship between free iron, fasting blood glucose (FBG) and glycated haemoglobin (HbA1c). Study was carried out on 50 type 2 diabetes cases under poor glycemic control associated with complications, 53 type 2 diabetes cases under good glycemic control and 40 healthy controls. We estimated free iron, both ferrous (Fe+2) and ferric (Fe+3) form, protein thiols, lipid hydroperoxides, FBG, HbA1c and serum ferritin levels in serum. There was a significant increase in free iron in Fe+3 state (p <0.01), HbA1c (p<0.01), serum ferritin (p<0.01), lipid hydroperoxides (p<0.01) and significant decrease in protein thiols (<0.01) in diabetes cases under poor glycemic control compared to diabetes cases under good glycemic control and healthy controls. Free iron correlated positively with HbA1c (p<0.01). Poor glycemic control and increase in glycation of haemoglobin is contributing to the increase in free iron pool which is known to increase oxidant generation.

Key Words: Free Iron, Glycated Hemoglobin, Ferritin

Full Text

The Full Text of this article is available as a PDF (46.8 KB).

References

  • 1.Tanner L.I., Lienhard G.E. Localization of transferrin receptors and insulin like growth factor II receptors in vesicles from 3T3-L1 adipocytes that contain intracellular transporters. J Cell Biol. 1989;108:1537–1545. doi: 10.1083/jcb.108.4.1537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Niederau C., Berger M., Stremmel W., Strake K., Stroymeyer G., Ebert R. Hyperinsulinemia in non-cirrhotic hemochromatosis: impaired hepatic degradation. Diabetolgia. 1984;26:441–444. doi: 10.1007/BF00262217. [DOI] [PubMed] [Google Scholar]
  • 3.Fernandez-Real J.M., Lopez-Bermejo A., Ricart W. Cross talk between the iron metabolism and diabetes. Diabetes. 2002;51:2348–2354. doi: 10.2337/diabetes.51.8.2348. [DOI] [PubMed] [Google Scholar]
  • 4.Lim S.C., Vaziri D.N. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int. 2004;65:1802–1809. doi: 10.1111/j.1523-1755.2004.00580.x. [DOI] [PubMed] [Google Scholar]
  • 5.Batey R.G., Lai Chung Fong P., Shamir S., Sherlock S. A non-transferrin bound serum iron in idiopathic hemochromotosis. Dig Dis Sci. 1980;25:340–346. doi: 10.1007/BF01308057. [DOI] [PubMed] [Google Scholar]
  • 6.Graham G., Bates G.W., Rachmilewitz E.A., Hershko C. Nonspecific serum iron in thalassemia:Quantitation and chemical reactivity. Am J Hematol. 1979;6:207–217. doi: 10.1002/ajh.2830060305. [DOI] [PubMed] [Google Scholar]
  • 7.Zager A.R., Johnson M.C.A., Hanson Y.S., Wasse H. Parenteral iron formulations: a comparative toxicologic analysis and mechanism of cell injury. Am J Kidney Dis. 2002;40:90–103. doi: 10.1053/ajkd.2002.33917. [DOI] [PubMed] [Google Scholar]
  • 8.Prakash M., Upadhya S., Prabhu R. Serum non-transferrin bound iron in hemodialysis patients not receiving intravenous iron. Clin Chim Acta. 2005;360:194–198. doi: 10.1016/j.cccn.2005.04.024. [DOI] [PubMed] [Google Scholar]
  • 9.Lim S.P., Wei H.Y., Yu L.Y., Kho B. Enhanced oxidative stress in hemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant. 1999;14:2680–2687. doi: 10.1093/ndt/14.11.2680. [DOI] [PubMed] [Google Scholar]
  • 10.Fujimoto S., Kawakami N., Ohara A. Non-enzymatic glycation of tranasferrin: decrease of iron binding capacity and increase of oxygen radical production. Biol Pharm Bull. 1995;16:396–400. doi: 10.1248/bpb.18.396. [DOI] [PubMed] [Google Scholar]
  • 11.Manoj K., Chakrobarthy A.S. Release of iron from hemoglobin — a possible source of free radicals in diabetes mellitus. Ind J Exp Biol. 1999;37:190–192. [PubMed] [Google Scholar]
  • 12.Wardman P., Candeias P.L. Fenton centennial symposium. Radiat Res. 1996;145:523–531. doi: 10.2307/3579270. [DOI] [PubMed] [Google Scholar]
  • 13.Lehen-Beyel, Groot H.D., Rauen U. Enhancement of iron toxicity in L929 cells by D-glucose: accelerated reduction. Biochem J. 2002;368:517–526. doi: 10.1042/BJ20020639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Harnett M.E., Stratton R.D., Browne R.W., Rosner B.A., Lanham R.J., Amstrong D. Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care. 2000;23(2):234–240. doi: 10.2337/diacare.23.2.234. [DOI] [PubMed] [Google Scholar]
  • 15.Ahmed N., Babael-Jadidi R., Howell S.K., Beisswenger P.J., Thornalley P.J. Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes. Diabetlogia. 2005;48(8):1590–1603. doi: 10.1007/s00125-005-1810-7. [DOI] [PubMed] [Google Scholar]
  • 16.Nilsson A.U., Bassen M., Savman K., Kjellmer I. A simple and rapid method for determination of free iron in biological fluids. Free Radic Res. 2002;36:677–684. doi: 10.1080/10715760290029128. [DOI] [PubMed] [Google Scholar]
  • 17.Motchnik A.P., Frei B., Ames N.B. Measurement of antioxidants in human blood plasma: protein thiols. In: Packer L., editor. Oxygen radicals in biological systems: Methods in Enzymology. California: Academic press; 1994. pp. 273–274. [DOI] [PubMed] [Google Scholar]
  • 18.Nourooz-Zadeh J. Ferrous iron oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. In: Packer L., editor. Oxidants and antioxidants: Methods in Enzymology. California: Academic press; 1999. pp. 58–62. [DOI] [PubMed] [Google Scholar]
  • 19.Nourooz-Zadeh J., Tajaddini Sarmadi J., McCarthy S., Betteridge J.D., Wolff P.S. Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes. 1995;44:1054–1058. doi: 10.2337/diabetes.44.9.1054. [DOI] [PubMed] [Google Scholar]
  • 20.Fairbanks V.F., Klee G.G. Biochemical aspects of hematology. In: Tietz N.W., editor. Fundamentals of clinical chemistry. 3rd ed. Philidelhia: WB Saunders; 1987. pp. 789–824. [Google Scholar]
  • 21.Trinder P. Determination of blood glucose using an oxidaseperoxidase system with an non-carcinogenic chromogen. J Clin Pathol. 1969;22(2):158–161. doi: 10.1136/jcp.22.2.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Klenk D.C., Hermanson G.T., Krohn R.I., Fujimoto E.K., Mallia A.C., Smith P.K., et al. Determination of glycosylated hemoglobin by affinity chromatography: Comparison with colorimetric and ion exchange methods and effects of common interferences. Clin Chem. 1982;28:2088–2094. [PubMed] [Google Scholar]
  • 23.Hider R.C. Nature of non-transferrin bound iron. Eur J Clin Invest. 2002;32(suppl1):50–54. doi: 10.1046/j.1365-2362.2002.0320s1050.x. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES